[{"id":"8dd5cc45-064d-481b-82c9-700d46c14228","acronym":"","url":"https://clinicaltrials.gov/study/NCT01234740","created_at":"2021-01-25T19:52:35.690Z","updated_at":"2024-07-02T16:37:11.475Z","phase":"Phase 1","brief_title":"Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases","source_id_and_acronym":"NCT01234740","lead_sponsor":"City of Hope Medical Center","biomarkers":" LYN • FYN","pipe":"","alterations":" ","tags":["LYN • FYN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e bafetinib (INNO-406)"],"overall_status":"Completed","enrollment":" Enrollment 7","initiation":"Initiation: 12/01/2010","start_date":" 12/01/2010","primary_txt":" Primary completion: 03/01/2013","primary_completion_date":" 03/01/2013","study_txt":" Completion: 03/01/2013","study_completion_date":" 03/01/2013","last_update_posted":"2018-04-17"}]